156 related articles for article (PubMed ID: 18850120)
1. Occupational risk of human Cytomegalovirus and Parvovirus B19 infection in female day care personnel in the Netherlands; a study based on seroprevalence.
Stelma FF; Smismans A; Goossens VJ; Bruggeman CA; Hoebe CJ
Eur J Clin Microbiol Infect Dis; 2009 Apr; 28(4):393-7. PubMed ID: 18850120
[TBL] [Abstract][Full Text] [Related]
2. Occupational risk for cytomegalovirus, but not for parvovirus B19 in child-care personnel in France.
de Villemeur AB; Gratacap-Cavallier B; Casey R; Baccard-Longère M; Goirand L; Seigneurin JM; Morand P
J Infect; 2011 Dec; 63(6):457-67. PubMed ID: 21867729
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
[TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of rubella virus, varicella zoster virus, cytomegalovirus and parvovirus B19 among pregnant women in the Sousse region, Tunisia].
Hannachi N; Marzouk M; Harrabi I; Ferjani A; Ksouri Z; Ghannem H; Khairi H; Hidar S; Boukadida J
Bull Soc Pathol Exot; 2011 Feb; 104(1):62-7. PubMed ID: 21243459
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy.
Wong A; Tan KH; Tee CS; Yeo GS
Singapore Med J; 2000 Apr; 41(4):151-5. PubMed ID: 11063178
[TBL] [Abstract][Full Text] [Related]
6. Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care.
van Rijckevorsel GG; Bovée LP; Damen M; Sonder GJ; Schim van der Loeff MF; van den Hoek A
BMC Public Health; 2012 Jun; 12():475. PubMed ID: 22726391
[TBL] [Abstract][Full Text] [Related]
7. Detection of cytomegalovirus, human parvovirus B19, and herpes simplex virus-1/2 in women with first-trimester spontaneous abortions.
Zhou Y; Bian G; Zhou Q; Gao Z; Liao P; Liu Y; He M
J Med Virol; 2015 Oct; 87(10):1749-53. PubMed ID: 25976377
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of parvovirus B19 infection in daycare educators.
Gilbert NL; Gyorkos TW; Béliveau C; Rahme E; Muecke C; Soto JC
Epidemiol Infect; 2005 Apr; 133(2):299-304. PubMed ID: 15816155
[TBL] [Abstract][Full Text] [Related]
9. Seropositivity of cytomegalovirus, parvovirus and rubella in pregnant women and recurrent aborters in Leningrad County, Russia.
Odland JØ; Sergejeva IV; Ivaneev MD; Jensen IP; Stray-Pedersen B
Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1025-9. PubMed ID: 11703200
[TBL] [Abstract][Full Text] [Related]
10. Population-based study on the seroprevalence of parvovirus B19 in Amsterdam.
van Rijckevorsel GG; Sonder GJ; Schim van der Loeff MF; van den Hoek JA
J Med Virol; 2009 Jul; 81(7):1305-9. PubMed ID: 19475607
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
Türk Dağı H; Ozdemir M; Baykan M; Baysal B
Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
[TBL] [Abstract][Full Text] [Related]
12. Detection of parvovirus B19, cytomegalovirus and enterovirus infections in cases of intrauterine fetal death.
Petersson K; Norbeck O; Westgren M; Broliden K
J Perinat Med; 2004; 32(6):516-21. PubMed ID: 15576274
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women.
Barlinn R; Vainio K; Samdal HH; Nordbø SA; Nøkleby H; Dudman SG
J Med Virol; 2014 May; 86(5):820-6. PubMed ID: 24114849
[TBL] [Abstract][Full Text] [Related]
14. Age-related immunoglobulin G seroprevalence of human parvovirus B-19 in Israeli children.
Miron D; Horovitz Y; Luder A; Ohnona FS; Schlesinger Y
Isr Med Assoc J; 2010 May; 12(5):277-9. PubMed ID: 20929079
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications.
Korndewal MJ; Mollema L; Tcherniaeva I; van der Klis F; Kroes AC; Oudesluys-Murphy AM; Vossen AC; de Melker HE
J Clin Virol; 2015 Feb; 63():53-8. PubMed ID: 25600606
[TBL] [Abstract][Full Text] [Related]
16. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum.
Gillespie SM; Cartter ML; Asch S; Rokos JB; Gary GW; Tsou CJ; Hall DB; Anderson LJ; Hurwitz ES
JAMA; 1990 Apr; 263(15):2061-5. PubMed ID: 2157074
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of parvovirus B19 in the German population.
Röhrer C; Gärtner B; Sauerbrei A; Böhm S; Hottenträger B; Raab U; Thierfelder W; Wutzler P; Modrow S
Epidemiol Infect; 2008 Nov; 136(11):1564-75. PubMed ID: 18198003
[TBL] [Abstract][Full Text] [Related]
18. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
van Gessel PH; Gaytant MA; Vossen AC; Galama JM; Ursem NT; Steegers EA; Wildschut HI
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):46-9. PubMed ID: 16406220
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and persistence of human parvovirus B19 infection in thalassemic patients.
Siritantikorn S; Kaewrawang S; Siritanaratkul N; Theamboonlers A; Poovorawan Y; Kantakamalakul W; Wasi C
Asian Pac J Allergy Immunol; 2007; 25(2-3):169-74. PubMed ID: 18035805
[TBL] [Abstract][Full Text] [Related]
20. [Parvovirus B19 seroprevalence in a group of schizophrenic patients].
El Kissi Y; Hannachi N; Mtiraoui A; Samoud S; Bouhlel S; Gaabout S; Boukadida J; Ben Hadj Ali B
Encephale; 2015 Dec; 41(6):470-6. PubMed ID: 25529557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
